KUNKL, ANNALISA
 Distribuzione geografica
Continente #
EU - Europa 651
Totale 651
Nazione #
IT - Italia 651
Totale 651
Città #
Genova 334
Genoa 123
Rapallo 117
Vado Ligure 76
Bordighera 1
Totale 651
Nome #
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 139
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 124
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 121
Clinical scale ex vivo expansion of cord blood-derived outgrowth endothelial progenitor cells is associated with high incidence of karyotype aberrations. 109
Amniotic fluid contains multipotent mesenchymal stromal cells with high proliferative potential and safety features: solid perspectives for clinical application 92
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML 34
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation 27
Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients 24
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 4
Totale 674
Categoria #
all - tutte 2.627
article - articoli 2.627
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 0 0 0 24 12 14 19 13 3
2020/202168 2 5 6 3 5 1 2 8 5 4 17 10
2021/202274 1 3 5 10 2 10 1 12 6 7 2 15
2022/2023139 11 15 2 18 22 21 0 6 15 7 22 0
2023/202495 1 11 1 11 8 22 3 20 3 3 6 6
2024/202586 9 15 7 16 13 25 1 0 0 0 0 0
Totale 674